Research never stops


Jan 08, 2018

Evotec and APEIRON achieve first milestone in immuno-oncology alliance with Sanofi

Hamburg, Germany and Vienna, Austria, 08 January 2018:
Evotec AG and APEIRON Biologics AG, a company focused on cancer immunotherapy, announced today that the companies received the first milestone payment

- read more
Jan 03, 2018

Evotec to attend upcoming investor conferences

Hamburg, Germany, 03 January 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting

- read more